BioCatalystWatch
LPCNWorkspace / LPCN / OverviewCompany library
Price
Market cap
Next catalystExpected 2H 2027LPCN 1154 (BRLIZIO) — BLOOM · Phase 3 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Other pipelines

LPCN 2101

GABAA receptor

PreINDP1P2P3FilingApproved
LPCN 2203

GABAA receptor

PreINDP1P2P3FilingApproved

Approved / commercial

Approved

PreINDP1P2P3FilingApproved

History / paused

LPCN 1154 (BRLIZIO)

GABAA receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

Androgen receptor (AR)

PreINDP1P2P3FilingApproved

Androgen receptor (AR)

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

LPCN PR & News

PR & News

LPCN SEC archive